Researchers have uncovered a promising therapeutic target for adenoid cystic carcinoma (ACC), a rare cancer of the salivary ...

NEW YORK, March 20, 2025 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP), a clinical-stage biotechnology company dedicated to developing novel treatments for cancer and viral infections ...

Data presented at European Molecular Imaging Meeting (EMIM 2025) for imaging with 68Ga-RAD202 confirms specific accumulation ...

In recently published work from Air Force Medical University, analysis of tumor tissues isolated from different patient-derived xenografts revealed significantly increased expression of FXYD5 in the ...

Radiopharm Theranostic (RADX)s announced a poster presentation at EMIM 20251, with findings that support the clinical utility of imaging and ...

as well as xenografts, which are development-stage organ products. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the ...

Data presented at European Molecular Imaging Meeting (EMIM 2025) for imaging with 68Ga-RAD202 confirms specific accumulation in the tumor, favorable biodistribution and low uptake in non-target organs ...

Using an unbiased approach, this important study discovered a role of Ezh2 in the differentiation of granule neuron precursors, the cell of origin for Shh group of medulloblastoma. Furthermore, the ...

After hours: March 17 at 4:42:31 PM EDT Loading Chart for UTHR ...

为解决非小细胞肺癌（NSCLC）治疗难题，研究人员探究 TIMM23 在 NSCLC 中的作用，发现其可作预后生物标志物和治疗靶点。 南昌大学第一附属医院等机构的研究人员开展了一项针对 NSCLC 的研究，相关成果发表在《Cell Death and Disease》上。该研究聚焦于线粒体相关蛋白 TIMM23（线粒体内膜转位酶 23），旨在探究其在 NSCLC 发生发展中的作用，这一研究为 ...